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Regulation 01" acetyleholine r ceptor (ACHE) 8one ©xpres~ion was aaal)'zed in :~-bun~larotoxtn (x-BTX) treated rats. A rcdtielion in available ~=~!-¢~. 
BTX binding sites wa~ accompanied by ~Ln increase in the various AChI~ transcripts. The inc-ease in th~ AChE ~-. p. r.. tend d.~ubur;it mgNAz 
was similar to theft ob.~rved in rats with exl~rimental tltolmmune n~ya~thenia gravis (EAMQ), Unlike in EAMO, the 7-subunit rltm:cripts re. 
apl~ared following a.BTX treau~ent. The quantitative dil!.'erenecs in the levels of AChE transcripts I~twcen ¢~.BTX treatmeltt and EAMG on 
one hand and dcnervation on the other hand, support the notion that the ~egulation of AChE gen~ espression is controlled by muscle activity 
and by n©urom~l fi~ctors as well, We also demonstrate in this r~port hat my;.~gcnin trun~.cfipts increase followinil =.BTX treating:at a~ ~11 as follow. 
in~l dencrvation, whereas MyoDI mtnser~pts remai~ stable. 
• -Bungarotoxin', Acetylcholine rcceplor transcript; Experimental utoimmune myttsth~.nia ~ravis; Dcnervation; M yollenin: MyoDI 
!. INTRODUCTION 
The nicotinic ace~ylcholine r ceptor (ACHE) of the 
vertebrate n~uromuscular junction (NMJ) is a major 
component of the end.plate post-synoptic membrane, It 
contains the acetylchoti,,e (ACh) binding sites, the ion 
channel and all ~hc structural elements required for 
regulation of its opening by ACh [I-4], It is composed 
of four homologous transmembrane subunits with a 
stoichiometry of c~zdg, d~during early embryonic stages 
or after denervation. In the adult form of the receptor 
an e-subunit substitutes the ~,-subunit. Der~ervation 
results in a large increase of newly synthesized AChEs, 
incorporated mostly into the extrajunctional p asma 
membrane, which have biophysical and biochemical 
properties distinct from those of junctional AChRs [5]. 
Northern blot hybridization experiments have shown 
that the expression of the ~,- and e-subunits correlates 
with the presence of the extrajunctional nd junctional 
forms of the receptor espectively, suggesting that the 
exchange of a single subunit can account for the dif- 
ferent properties observed after denervation of during 
development [5,6]. 
Recently, anew family of proteins involved in regula- 
tion of myogenic lineage and containing the helix-loop- 
helix motif has been isolated, among which are MyoDl 
and myogenin [7,8]. MyoD1 is expressed in both 
myoblasts and myofibers [7], while myogenin is absent 
in myoblasts and is expressed uring differentation i to 
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myofibers [8]. Two MyoDl and :llyogenin binding 
sites, in muscle-specific enhancers of the chicken AChE 
a,-subunit gone, were found to be functional for activity 
of the a,-subunit in transfected myotubes [9], implying 
that myogenic factors may regulate the AChE or. 
subunit promoter. 
AChE is the major autoantigen i myasthenia graves 
(MG) and in its animal model experimental utoim- 
mune myasthenia gravis (EAMG) [10]. The immune at- 
tack at the NMJ leads to a decreased AChR content in 
the post-synoptic membrane and impairs signal trans- 
duction from nerve to muscle, Similarly, administration 
of sublethal doses of ~-bungarotoxin (ce-BTX) into 
animals causes a block of the AChR., leading to muscle 
weakness and an electrophysiological picture which 
resemble those of EAMG [13], In contrast o denerva- 
tion, in both myasthenia nd ce.BTX treatment the 
nerve remains in contact with the muscle. 
We have previously demonstrated that the reduction 
in AChE content observed in EAMG is accompanied by 
an increase in AChR transcripts coding for the adult 
type of the receptor (~z6'e6) [11,12]. In this report, we 
have analyzed the effects of o~-BTX treatment on AChR 
g2ene xpression using Northern blot hybridization with 
P-labelled DNA probes for the different AChR 
subunits. In addition we have studied the regulation of 
MyoD1 and myogenin gone expression during ,~-BTX 
treatment and following denervation. 
2. MATERIALS AND METHODS 
2.1. Animal models 
Ten-week-old female Lewis rats were intraperitoneally injected 
with o~BTX (27 #g/kg body weight/day) in phosphate-buffered saline 
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tPlt~I for $ ,;onweuflve da~'~, while ¢onl~'~l animal., w~re In~'~t~d wlth 
PItS alotw. Animah were ~aedtl.~ed from aap I Io d~ 1~ alter ||!¢ 
tirol injw|ten, lll~tr hindllmb rnu~¢l~ were Immediately rema~'¢d. 
frot~tl in li¢luid nilro~en ~nd ~tored ~I -7tt~¢ " undl ~e .  Aliquo~t or 
Ilt¢ mu~¢l¢~ were u~d !o measure r~idual a.I~TX bindlnll ~ I~ or ¢o 
itola1¢ RNA. EAMG wa, lndu¢¢¢i tr~ raft by Inj¢~tln=! d~em monthl~ 
wi|h 40 ~,~ or purified Tt~rt~lu ¢ullf~rnk'tt AChR in el=replete 
Freund'~ =djuvaa~ (CFA) ~mtll my~tsti~enie ~ymptomt were observed 
| I l l .  For d~nervadon, ~nimal~ w~r¢ an=slhetited and I em of the 
~¢latl~ nerve w~ ~url!ieally remowd, and =tiler two weeks, lh¢~" wer~ 
tagrltteed and tnus¢l¢~ w~rr~ r~moved and ~|ored a~ for ¢~.l~TX.treat~d 
rat~, 
2.2. ¢|C°h/~ ¢,~'l¢a¢tiOt! 
~ht~¢l~ AChR preparalion, from the hindlin~b of rat~ were per. 
t'orm~d e~t*,~ntially ~tdescribed pr~vioud~, !14 I. In brier, mu~de all. 
quot~ were bomo~teni,~ed at4 'C  In PflS. ¢entrift~l~ed at 20,000 ~ ~ and 
lh= pellet~ ¢~traeted with I~  Trilon X-100 tn PBS, The ~t=pertlalanl 
oblained felh~wtnl~ eenlrit't~lta|ton for 60 rain at 100,000 ~/~ wa~ used. 
The re~tdu~d membranat AChR ¢011lgi'il tvar= d~termined bymea~nrinl~ 
the btndinit of ~"*I.;BYX a~ previously described l|~l. 
2,3. Narthern blot .nal, v~lx 
Total tltus~:le RNA was cxlracled =s previously, described [111. 
Followini~ 1~, agaro~e rormaldeh:,,~le i~cl eleclrophore~i~, RNA was 
transferred toOene$¢reen Plu~ (NEN, D~I Pont) I'ilter~ [I 11. Northern 
biols of total RNA were hybridized to eDNA probes pecific for Ihc 
dirf~r~nt AChR ~;ubun~t~.: the ~r., .~. and ~.r, ubunit probe~, were E¢oRI 
fragments derived from tire respective tt~ous~ recombinant DNA 
(kindly provided by Dr, S. |,tcin~:mana), the ~.~ubunit probe wa~ an 
/:~'oR I fragment at~d the -,r.~ubunll: probe wa~ a Xb#l/Sall fral~ment, 
both derived from rat recombinant DNA (kindly provided by Dr, V, 
Witzemanr~), The ~.aetin.,'~pe¢ifi¢ probe (kindly provided by Dr, U, 
Nudel) wa~ ~ 600 bp rat eDNA, The MyoDI probe (kindly provided 
by Dr A,B, Lapser) wa,,i a ra~ eDNA rragntent ant1 was cleaved out 
of tl~e vector pEMCI IS with EcoRI, The myogenin probe (kindly pro. 
vicled by Dr, W.E, Wright) was a rat eDNA fragntent and waseleaved 
out of the pESVMGN vector with EcoRl, Autoradiograms of the 
Northern biers were sc~nnecl through :t Molecular Dynamics 300A 
Computing Densitometer using the hnageQual~t Software to gel 
volume integration (total O,D, in the area of the signal), Averages or 
tile results from 3 different blots were calculated, 
3. RESULTS 
In our previous reports [11,12] we analyzed AChR 
gene expression i EAMG in rabbits, rats, and mice and 
found that an increase in AChR transcripts correlates 
exclusively with the expression of the disease and with 
a significant reduction in membranal AChR content. 
The moderate increase of AChR gene expression 
observed in EAMG corresponds mainly to an adult 
junctional receptor (~2/3~c5). In order to further under- 
stand the mechanism of AChR gene regulation, we have 
analyzed the effect of a specific blockade of ACh- 
induced muscle activity on AChR gene expression, 
using a system other than EAMG. For this purpose we 
have chosen to use o~-BTX, which is a specific an- 
tagonist of AChR [16], and its effect mimics in several 
aspects those observed in EAMG. Rats were injected 
with a-BTX (27 #g/kg of body weight/day) for 5 con- 
secutive days and clinical symptoms resembling EAM(3 
were observed: rats were weak, decreased their spon- 
taneous movements in the cage and lost weight (up to 
25-30°70). The symptoms disappeared in a few days 
after die end of the treatment, and on day 9 or 10 ex- 
perimental and control rats were indis|ingutshable in 
their behavior or body weight. Tile clinical picture was 
accompanied, by a protlre~ive decrease of residual 
detectable I=sI-t~-BTX binding to muscle extracts (Fig. 
I1), From day 6 on detectable ¢~.BTX binding increased 
8radually, and reached about 60% of its level before 
treatment (day 0) from day lO to day 15 (Fig. l). 
Northern blot analysis of total RNA preparations 
(Fig. 2) showed maximal evels of the specific mRNAs 
coding for the ~-. B-, e- and 6-subunits on day 5, 
reaching 7.5-, 5-, 4, 5- and 6.$-foid increases respective- 
ly, The ~-subunit mRNA was not detectable in control 
animals, while it could be detected between day 4 and 
day 9 in treated rats, with a peak on day 6. Pretreatment 
levels of all AChR subunit transcripts were reached 
again between days 8 and 10. No significant variation in 
¢~-actin mRNA was recorded, reflecting the selective in- 
crease in all AChR mRNAs in et.BTX treated rats; Con- 
trol rats, receiving PBS alone, did not show any clinical 
symptoms, nor any change in mRNA levels or in mere- 
brahe AChR content. 
The increase of a-subunit mRNA, following ~-BTX 
treatment is comparable to the increase observed in 
EAMG (5-7 fold) and is about one order of  magnitude 
lower than the increase observed following denervation 
(Fig. 3). The differences in the regulation of the a- and 
the .,/.subunit mRNA in EAGM, t~-BTX treatment and 
denervation, may imply that different mechanisms are 
controlling AChR gene expression i  these systems. 
Since MyoDl and myogenin were shown to affect 
AChR gene expression during myogenesis in chick 
myotubes [9], we compared the changes of AChR c~- 
subunit mRNA levels with those of MyoDl and 
myogenin mRNAs following a.BTX treatment (Fig. 4). 
For comparison we have also measured the levels of 
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Fig. 1. Residual ~251-a-BTX binding sites in rat muscle extracts 
following t~-BTX treatment, The arrows indicate the days of injection 
of o:-BTX, 
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Fig. 2. Northern blot analysis of AChR mRNAs following ~.BTX 
treatment. Total RNA samples (30 #g/lane) were hybridized wi:h 
cDNA probes specific for: (A) ~-subunit, (B) ~3.subunit~ (C) 3'- 
subunit, (D) e-subunit, IE) ~5-subunit and (F) ~-actin. The relative con- 
tent of the respective suhunits mRNAs was plotted assigning the ar- 
bitrary value of I for control non-treated rats (day 0). The left inserts 
show the autoradigrams of Northern blots, where (a) corresponds to 
control (day 0) and (b) to the peak for each of the subunits. The blots 
were hybridized with the AChR eDNA probes and following strip- 
ping, with the c~-actin probe. 
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Fi~, 3. NOrlherll blol analysis with total RNA (]0 ,.Iptl~n¢] . f  rat 
ACIIR ¢t.r, ubunit mRNA in (.)t:o.trol. (b) ~.BTX treatment, (~) 
EAMG, (d] denerv~,tion. 
transcripts in a-BTX treated rats preceded that of  the a-  
subuni t  mRNA.  For instance,  on days 3 and  4 the levels 
of c¢-subtmit mRNA were rather low, whereas that o f  
myogenin  was high and reached almost its maximal 




28 S. i 
18S.  
, I 
'~ 0 2 4 6 8 Io 
OQys 28 S- 
i =o 6 [ ~- act~ nI t I T ; ; 1 S , 7 T 
0 2 4 6 8 IO 
Doys 28 S, 
18S-  
28 S. 
t reatment  and in denervat ion MyoD1 mRNA levels re- 
ma ined  stable, while those of myogen in  were 
signif icantly elevated. Moreover,  the changes in 
myogen in  as well as in a -subun i t  mRNAs  after denerva- 
t ion are much higher than those observed following a-  
BTX treatment.  The relative increase in the myogenin 
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Fig. 4. Levels of transcripts specific for AChR cz-subunit, myogenin, 
MyoDI al~d c~.octin following {A) denervation and (B) ~.BTX treat- 
ment; numbers indicate days after the first injection. Total muscle 
RNA samples (30 ~g/lane) were subjected to Northern blot t~ybridiza- 
tion analysis as described; the autoradiograms represent one blot 
which was stripped and hybridized each time with the different eDNA 
probes. 
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Fi~, ~, locv~Is of spe¢ific transcripts rot ,~,subtmit Ie), myosenin (~) 
,nd MyoDI t~) follos~inlt ¢¢-BTX t reatmcnl. The relative ~+alues were 
tl~l~rn'dned by densltomelric scannln~h aSSilminll an ~rbh rary vMuc of 
I for control non.lrcated r~tts (day O). 
4, DISCUSSION 
c~-BTX has been used widely as a specific antagonist 
for tl~e AChR with a high affinity and specificity, both 
in vivo and in vitro [181, When injected in vivo, its bind- 
ing to AChR causes muscular weakness and an clec- 
trophysiological picture similar to those observed in 
MG and EAMG [131. In this report we have shown that 
a blockade of cholinergic neuromuscular t ansmission 
by ¢t-BTX causes a moderate increase in all AChR 
transcripts. The time-course for the increase in AChR 
mRNAs is similar for all subunits, except for a slight 
varmtion observed with the -v-subunit (Fig. 2). 
[t has already been demonstrated that denervation of 
adult rat muscle elicited an increase of the steady-state 
level of the receptor subunit mRNAs [3,17-19]. The 
newly synthesized receptor following denervation, is 
maigly of  the embryonic, extrajunctional type (c~2/3y~5) 
[5,6,21]. The y-subunit mRNA is not detected in nor- 
real innervated adult muscles, while upon denervation, 
a large increase in its level is observed [5,19], On the 
other hand, in EAMG the increase in AChR subunit 
mRNAs corresponds mainly to the adult, junctional 
form of the receptor (c~2~e~5) [11,12]. The levels of 
AChR a-subunit mRNA m myasthenic rats and ~- 
BTX-treated rats show a similar increase, 5- to 7-fold, 
which is about one order of magnitude lower than that 
observed in denervated muscles (Fig, 3). However, it 
should be noted that the y-subunit ranscript reappears 
following c~-BTX treatment; his is qualitatively similar 
to denervation and distinct from EAMG. Although 
muscle activity is impaired in both EAMG and c~-BTX 
treatment, he contact between erve and muscle is not 
affected as is the case in denervation. Thus, the 
moderate increase in AChR transcripts following c¢- 
BTX treatment and in EAMG suggests that ACh- 
induced muscle activity is sufficient for the regulation 
of  AChR gene expression. Nevertheless, the large in- 
crease in receptor transcripts observed following richer- 
rat ion supports the notion that the regulation of AChR 
gene expression is controlled not only through muscle 
activity, but also by neuronal factors other than ACh. 
AChR transcripts were shown to be elevated only 
beyond a threshold loss of  available AChR binding 
sites. Later on. an inverse correlation between I~SI.c~. 
BTX binding sites and AChR transcripts is observed 
(Fig, 2), Thus, the elevation in AChR subunits mRNA 
was observed between day 3 and day 9, when the mem- 
brane receptor was below 60% of its value before treat- 
meat. A similar effect was reported in EAMG, where 
the rise in AChR transcripts was triggered only beyond 
a certain threshold loss in receptor content [121. 
In this study we have observed that et-BTX treatment 
and denervation induced an elevation of  myogenin 
transcripts, while MyoDI mRNA levels remained cons- 
tant, Myogenin is transiently expressed following a 
stimulation to differentiate, while MyoDI is coati. 
nuously expressed in myoblasts as well as in myofibers 
118]. In addition myogenin is expressed in at least one 
muscle cell line (L~) in which MyoDI could not be 
detected, and in myotomes at least 2 days before 
MyoDI [8]. MyoDl  and myogenin belong to the same 
DNA-binding protein superfamilly (the helix-loop- 
helix), both share a domain with a very high degree of  
homology and may function in conjunction with one 
another. Nevertheless, it is possible that some of the ef- 
fects of  myogenin might be independent from MyoDI,  
It was proposed recently that MyoDl  and myogenin 
may regulate certain muscle-specific genes such as mus- 
cle creatine kinase [201 and AChR genes [9]. Our data 
indicate that there is a good correlation between the 
relative increase in myogenln mRNA and that of c~. 
subunit mRNA in denervation and following c~-BTX 
treatment (Fig. 4). In addition, the fact that the increase 
in myogenin mRNA precedes that of  the AChR c~- 
subunit (Fig, 5), along with previous data [9], indicates 
that myogenin can be implicated in controlling AChR 
c~-subunit gene expression, Since we did not observe a 
change in MyoD 1 transcripts in these systems we cannot 
conclude whether MyoDI participates with myogenin in 
controlling c~-subunit gene expression. 
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